
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Flagship Pioneering
Deal Size : $50.0 million
Deal Type : Financing
Flagship’s Abiologics sets sail with $50M for synthetic protein R&D
Details : The proceeds will advance company's platform and develop a diverse pipeline of medicines, Synteins, with an initial focus on oncology and immunology indications.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 23, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Flagship Pioneering
Deal Size : $50.0 million
Deal Type : Financing
